InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54
United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

135
Insider
Date
Role
Action
Shares
Price
Amount
Rashmi Kumar
8 Jun 2026
Director
Sold on a plan
15,000
$4.46
$66.84K
Paul Bisaro
14 May 2026
Director
Buy
7,500
$3.69
$27.64K
Samraat S. Raha
9 Mar 2026
President and CEO
Buy
40,000
$5.00
$199.84K
S. Louise Phanstiel
27 Feb 2026
Director
Buy
48,000
$4.66
$223.73K
S. Louise Phanstiel
26 Feb 2026
Director
Buy
50,407
$4.80
$242.10K
S. Louise Phanstiel
25 Feb 2026
Director
Buy
6,100
$4.74
$28.89K
Paul J Diaz
11 Oct 2024
President and CEO
Sold on a plan
15,000
$22.93
$343.95K
Dale Muzzey
11 Sep 2024
Chief Scientific Officer
Sell
2,100
$26.17
$54.96K
Paul J Diaz
11 Sep 2024
President and CEO
Sold on a plan
15,000
$26.72
$400.80K
Heinrich Dreismann
9 Sep 2024
Director
Sell
10,000
$27.05
$270.52K
Colleen F Reitan
3 Sep 2024
Director
Sold on a plan
46,012
$27.95
$1.29M
Margaret Ancona
21 Aug 2024
SVP, Chief of Staff
Sell
11,538
$27.82
$320.99K
Rashmi Kumar
19 Aug 2024
Director
Sold on a plan
7,500
$28.01
$210.08K
Daniel K Spiegelman
4 Jun 2024
Director
Sold on a plan
3,788
$22.05
$83.53K
Daniel K Spiegelman
3 Jun 2024
Director
Sold on a plan
3,788
$22.04
$83.49K
Paul J Diaz
15 May 2024
President and CEO
Sell
75,000
$25.07
$1.88M
Paul J Diaz
14 May 2024
President and CEO
Sell
95,000
$25.21
$2.39M
Lee Nisley Newcomer
13 May 2024
Director
Sell
6,200
$25.30
$156.86K
Paul J Diaz
13 May 2024
President and CEO
Sell
57,844
$25.13
$1.45M
Richard Bryan Riggsbee
1 Dec 2023
Chief Financial Officer
Sold on a plan
30,000
$19.09
$572.84K
Richard Bryan Riggsbee
1 Nov 2023
Chief Financial Officer
Sold on a plan
30,000
$15.69
$470.62K
Daniel K Spiegelman
2 Jun 2023
Director
Sell
8,638
$23.01
$198.76K
Nicole Lambert
27 Mar 2023
Chief Operating Officer
Sell
6,433
$23.48
$151.05K
Nicole Lambert
2 Mar 2023
Chief Operating Officer
Sell
13,184
$22.74
$299.82K
Richard Bryan Riggsbee
2 Mar 2023
Chief Financial Officer
Sell
15,000
$22.55
$338.25K
Richard Bryan Riggsbee
20 Jan 2023
Chief Financial Officer
Sell
9,400
$20.04
$188.39K
Richard Bryan Riggsbee
18 Jan 2023
Chief Financial Officer
Sell
600
$20.01
$12.01K
Richard Bryan Riggsbee
27 Dec 2022
Chief Financial Officer
Sell
20,000
$15.15
$302.99K
Daniel K Spiegelman
6 Jun 2022
Director
Sell
6,424
$19.25
$123.67K
Jayne B. Hart
28 Feb 2022
Chief People Officer
Sold after exercise
3,500
$25.00
$87.50K
Jayne B. Hart
28 Feb 2022
Chief People Officer
Sold after exercise
7,000
$25.00
$175.00K
Nicole Lambert
1 Oct 2021
See Remarks
Sell
1,420
$31.57
$44.83K
Nicole Lambert
27 Sep 2021
See Remarks
Sell
10,112
$33.10
$334.75K
Jerry S Lanchbury
23 Sep 2021
Chief Scientific Officer
Sell
200
$35.06
$7.01K
Jayne B. Hart
17 Sep 2021
Chief People Officer
Sold after exercise
2,966
$33.72
$100.01K
Jayne B. Hart
17 Sep 2021
Chief People Officer
Sold after exercise
64,480
$33.72
$2.17M
Nicole Lambert
27 Aug 2021
See Remarks
Sell
945
$34.50
$32.60K
Jerry S Lanchbury
24 Aug 2021
Chief Scientific Officer
Sold after exercise
30,000
$35.57
$1.07M
Jerry S Lanchbury
23 Aug 2021
Chief Scientific Officer
Sold after exercise
40,000
$35.07
$1.40M
Jerry S Lanchbury
23 Aug 2021
Chief Scientific Officer
Sold after exercise
10,000
$35.57
$355.70K
S. Louise Phanstiel
5 Aug 2021
Director
Sold after exercise
47,881
$35.04
$1.68M
Jerry S Lanchbury
5 Aug 2021
Chief Scientific Officer
Sold after exercise
28,225
$35.57
$1.00M
Jerry S Lanchbury
4 Aug 2021
Chief Scientific Officer
Sold after exercise
11,775
$35.57
$418.86K
Jerry S Lanchbury
4 Aug 2021
Chief Scientific Officer
Sold after exercise
38,225
$35.24
$1.35M
Dennis Langer
3 Aug 2021
Director
Sold after exercise
30,000
$34.75
$1.04M
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
4,170
$34.00
$141.78K
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
27,830
$34.00
$946.22K
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
1,775
$35.07
$62.25K
Jerry S Lanchbury
3 Aug 2021
Chief Scientific Officer
Sold after exercise
16,225
$33.99
$551.49K
Richard Bryan Riggsbee
3 Aug 2021
Chief Financial Officer
Sell
14,983
$35.14
$526.48K
Jerry S Lanchbury
13 Jul 2021
Chief Scientific Officer
Sold after exercise
40,000
$33.74
$1.35M
Jerry S Lanchbury
13 Jul 2021
Chief Scientific Officer
Sold after exercise
3,295
$33.69
$111.01K
Jerry S Lanchbury
12 Jul 2021
Chief Scientific Officer
Sold after exercise
13,295
$33.55
$446.08K
Jerry S Lanchbury
12 Jul 2021
Chief Scientific Officer
Sold after exercise
36,705
$33.55
$1.23M
Jerry S Lanchbury
9 Jul 2021
Chief Scientific Officer
Sold after exercise
17,692
$32.47
$574.46K
Jerry S Lanchbury
9 Jul 2021
Chief Scientific Officer
Sold after exercise
5,603
$32.29
$180.92K
Jerry S Lanchbury
9 Jul 2021
Chief Scientific Officer
Sold after exercise
26,705
$32.79
$875.66K
Jerry S Lanchbury
7 Jul 2021
Chief Scientific Officer
Sold after exercise
1,884
$31.99
$60.27K
Jerry S Lanchbury
7 Jul 2021
Chief Scientific Officer
Sold after exercise
30,424
$32.29
$982.39K
Jerry S Lanchbury
28 Jun 2021
Chief Scientific Officer
Sold after exercise
948
$32.49
$30.80K
Jerry S Lanchbury
28 Jun 2021
Chief Scientific Officer
Sold after exercise
1,891
$32.23
$60.95K
Jerry S Lanchbury
28 Jun 2021
Chief Scientific Officer
Sold after exercise
3,973
$32.43
$128.85K
Jerry S Lanchbury
25 Jun 2021
Chief Scientific Officer
Sold after exercise
33,372
$31.61
$1.06M
Jerry S Lanchbury
25 Jun 2021
Chief Scientific Officer
Sold after exercise
28,640
$31.97
$915.62K
Jerry S Lanchbury
25 Jun 2021
Chief Scientific Officer
Sold after exercise
21,360
$32.47
$693.56K
Daniel K Spiegelman
17 Jun 2021
Director
Sell
3,139
$30.52
$95.79K
Daniel K Spiegelman
28 May 2021
Director
Sell
7,142
$28.99
$207.02K
Jerry S Lanchbury
4 May 2021
Chief Scientific Officer
Sold after exercise
19,360
$31.97
$618.95K
Jerry S Lanchbury
27 Apr 2021
Chief Scientific Officer
Sold after exercise
40,000
$31.47
$1.26M
Nicole Lambert
19 Apr 2021
See Remarks
Sell
5,890
$27.01
$159.09K
Nicole Lambert
19 Apr 2021
See Remarks
Sell
759
$27.01
$20.50K
Jayne B. Hart
29 Mar 2021
Chief People Officer
Sold after exercise
8,034
$30.00
$241.02K
Jayne B. Hart
29 Mar 2021
Chief People Officer
Sold after exercise
21,966
$30.00
$658.98K
Jayne B. Hart
29 Mar 2021
Chief People Officer
Sold after exercise
28,000
$30.00
$840.00K
Jerry S Lanchbury
16 Feb 2021
Chief Scientific Officer
Sold after exercise
5,555
$29.71
$165.06K
Jerry S Lanchbury
16 Feb 2021
Chief Scientific Officer
Sold after exercise
74,445
$29.71
$2.21M
Paul Parkinson
8 Jan 2021
EVP Strategy and Innovation
Sell
11,824
$25.00
$295.60K
S. Louise Phanstiel
11 Nov 2020
Director
Buy
15,000
$16.62
$249.34K
Alexander Ford
15 Sep 2020
Chief Operating Officer
Sell
2,804
$13.78
$38.63K
Nicole Lambert
12 Feb 2020
President, MGL
Sell
4,354
$19.73
$85.91K
Alexander Ford
5 Feb 2020
President, MWH
Sell
7,273
$30.00
$218.19K
Alexander Ford
26 Dec 2019
President, MWH
Exercised, kept
1,307
$15.98
$20.89K
Walter Phd Gilbert
13 Dec 2019
Director
Buy
5,860
$25.60
$150.00K
John T Henderson
7 Nov 2019
Director
Buy indirect
1,750
$23.46
$41.06K
John T Henderson
7 Nov 2019
Director
Buy
5,250
$23.46
$123.17K
Richard Bryan Riggsbee
1 Aug 2019
Chief Financial Officer
Sell
25,000
$41.50
$1.04M
Bernard Tobin
1 Aug 2019
President Crescendo BioScience
Sell
11,712
$40.00
$468.48K
Gary A. King
1 Aug 2019
Exec. VP International Ops
Sold after exercise
20,000
$39.44
$788.81K
Gary A. King
1 Aug 2019
Exec. VP International Ops
Sold after exercise
10,000
$43.48
$434.82K
Gary A. King
1 Aug 2019
Exec. VP International Ops
Sold after exercise
30,000
$46.19
$1.39M
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
3,862
$44.00
$169.93K
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
58,138
$44.00
$2.56M
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
4,328
$44.00
$190.43K
Mark Christopher Capone
1 Aug 2019
President & C.E.O.
Sold after exercise
70,672
$44.00
$3.11M
Ralph L McDade
12 Mar 2019
President Myriad RBM, Inc.
Sell
1,975
$31.00
$61.23K
Mark Christopher Capone
11 Jul 2018
President & C.E.O.
Sold after exercise
2,346
$41.00
$96.19K
Mark Christopher Capone
11 Jul 2018
President & C.E.O.
Sold after exercise
77,654
$41.00
$3.18M
Richard M Marsh
11 Jul 2018
E.V.P., General Counsel
Sold after exercise
40,000
$42.02
$1.68M
Richard M Marsh
11 Jul 2018
E.V.P., General Counsel
Sold after exercise
30,672
$44.00
$1.35M
John T Henderson
11 Jul 2018
Director
Sold after exercise
10,000
$40.17
$401.70K
John T Henderson
11 Jul 2018
Director
Sold after exercise
10,000
$42.01
$420.09K
John T Henderson
11 Jul 2018
Director
Sold after exercise
10,000
$44.00
$440.00K
Jerry S Lanchbury
11 Jul 2018
Chief Scientific Officer
Sold after exercise
3,861
$43.34
$167.34K
Jerry S Lanchbury
11 Jul 2018
Chief Scientific Officer
Sold after exercise
46,139
$43.34
$2.00M
Richard M Marsh
18 Jun 2018
E.V.P., General Counsel
Sold after exercise
33,000
$40.00
$1.32M
Jerry S Lanchbury
18 Jun 2018
Chief Scientific Officer
Sold after exercise
2,346
$40.12
$94.12K
Jerry S Lanchbury
18 Jun 2018
Chief Scientific Officer
Sold after exercise
57,654
$40.12
$2.31M
Dennis Langer
8 Jun 2018
Director
Sold after exercise
13,664
$39.35
$537.68K
Dennis Langer
7 Jun 2018
Director
Sold after exercise
3,096
$39.35
$121.83K
Walter Phd Gilbert
6 Jun 2018
Director
Sold after exercise
1,189
$39.80
$47.32K
Dennis Langer
6 Jun 2018
Director
Sold after exercise
3,609
$39.37
$142.09K
Dennis Langer
5 Jun 2018
Director
Sold after exercise
1,227
$39.90
$48.96K
Walter Phd Gilbert
5 Jun 2018
Director
Sold after exercise
28,811
$39.68
$1.14M
Dennis Langer
4 Jun 2018
Director
Sold after exercise
8,404
$39.90
$335.32K
Dennis Langer
4 Jun 2018
Director
Sold after exercise
10,000
$39.90
$399.00K
Dennis Langer
1 Jun 2018
Director
Sold after exercise
30,000
$38.90
$1.17M
Dennis Langer
30 May 2018
Director
Sold after exercise
10,000
$37.92
$379.25K
Richard M Marsh
30 May 2018
E.V.P., General Counsel
Sold after exercise
33,139
$38.00
$1.26M
Mark Christopher Capone
30 May 2018
President & C.E.O.
Sold after exercise
90,000
$38.00
$3.42M
Dennis Langer
21 May 2018
Director
Sold after exercise
10,000
$35.90
$359.00K
Richard M Marsh
22 Jan 2018
E.V.P., General Counsel
Sold after exercise
37,654
$40.25
$1.52M
Gary A. King
22 Jan 2018
Exec. VP International Ops
Sold after exercise
4,445
$39.03
$173.49K
Gary A. King
22 Jan 2018
Exec. VP International Ops
Sold after exercise
30,000
$39.77
$1.19M
Gary A. King
18 Jan 2018
Exec. VP International Ops
Sold after exercise
3,120
$38.12
$118.93K
Richard M Marsh
18 Jan 2018
E.V.P., General Counsel
Sold after exercise
40,000
$38.25
$1.53M
Richard M Marsh
12 Jan 2018
E.V.P., General Counsel
Sell
13,759
$36.25
$498.76K
Walter Phd Gilbert
14 Dec 2017
Director
Sell
7,500
$33.19
$248.93K
Heinrich Dreismann
11 Dec 2017
Director
Sell
6,000
$33.50
$201.00K
Alexander Ford
13 Nov 2017
President, MGL
Sell
3,031
$31.64
$95.90K
John T Henderson
1 Sep 2017
Director
Sold after exercise
10,000
$30.30
$302.98K
John T Henderson
1 Sep 2017
Director
Sold after exercise
10,000
$30.30
$303.00K
John T Henderson
1 Sep 2017
Director
Sold after exercise
10,000
$30.31
$303.06K
John T Henderson
23 Feb 2017
Director
Buy
400
$18.57
$7.43K
John T Henderson
23 Feb 2017
Director
Buy
3,600
$18.58
$66.89K
John T Henderson
22 Feb 2017
Director
Buy
2,000
$18.81
$37.61K

What was left out

Form 4 filings counted 546
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 78
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 15,234,074
Sales filed before the plan box existed 26
History held since 18 Oct 2006